RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.63) per share. This is unchanged from the same period last year.
Smith+Nephew Receives Innovative Technology Contract From Vizient For PICO Single Use Negative Pressure Wound Therapy Systems
Contract awarded for products that bring improvement to healthcare industryLONDON, May 2, 2023 /PRNewswire/ -- Smith+Nephew ((LSE: SN, NYSE:SNN), the global medical technology company, today announces its PICO Single Use
